ID

38074

Descripción

Two-Part Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Oral Dosesof the Enteric-Coated Free Base Formulation of Darapladib (SB-480848) ina Dose Rising Fashion and to Evaluate the Safety, Tolerability and Pharmacokinetics of Darapladib when Co-administered with Ketoconazole in Healthy Adult Subjects. There are 4 parts to this study: Screening, Part A, Part B, and Follow-Up. Part A contains 2 Sessions per day for day 1-10, Part B contains 1 Session per day for day 1-14. Each itemgroup contains information when it should be filled out. The itemgroups of the non-serious and serious adverse event forms contain additional information on the definition of a serious/non-serious adverse event.

Palabras clave

Versiones (1)
  1. 15/9/19 15/9/19 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

15 de septiembre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Darapladib Evaluation Case Report Form GSK LPL107988

Inglés

Laboratory Results

12 formularios  
Administrative documentation
Descripción

Administrative documentation

Alias
UMLS CUI-1
C1320722
Subject Identifier
Descripción

Subject Identifier

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Visit Date
Descripción

Visit Date

Tipo de datos

date

Alias
UMLS CUI [1]
C1320303
Liver Events Assessment
Descripción

Liver Events Assessment

Alias
UMLS CUI-1
C0023901
UMLS CUI-2
C0441471
Have liver chemistry (ALT, AST, alkaline phosphatase, total bilirubin, or Gammaglutamyltranspeptidase) results reached or exceeded protocol-defined investigational product stopping criteria?
Descripción

If Yes, stop investigational product, complete date stopped on Investigational Product form, contact GSK within 24 hours of occurrence, complete Liver Events Form and obtain the following tests: • PK blood sample within 24 hours of last dose (or 3x the investigational product half-life or t1/2) • Hepatitis A: Hepatitis A lgM antibody. • Hepatitis B: Hepatitis B surface antigen and Hepatitis B Core Antibody (lgM). • Hepatitis C: Hepatitis C RNA. • Hepatitis E IgM antibody (if subject resides or has travelled in past 3 months outside the USA or Canada). • Cytomegalovirus IgM antibody (CMV) • EBV (Epstein Barr viral capsid antigen IgM antibody) or if unavailable, obtain heterophile antibody or monospot testing. • CPK (serum creatine phosphokinase) • LDH (lactate dehydrogenase) • Bilirubin fractionation, if bilirubin >1.5xULN

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023901
UMLS CUI [1,2]
C0439093
UMLS CUI [1,3]
C2348563
UMLS CUI [1,4]
C2746065
UMLS CUI [1,5]
C0243161
UMLS CUI [2]
C0001899
UMLS CUI [3]
C0004002
UMLS CUI [4]
C0002059
UMLS CUI [5]
C0368753
UMLS CUI [6]
C0017040
Pharmacokinetics Blood
Descripción

Pharmacokinetics Blood

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0005767
Date and actual time sample taken
Descripción

Date and actual time sample taken

Tipo de datos

datetime

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C1277698
UMLS CUI [2,1]
C0237400
UMLS CUI [2,2]
C0040223
UMLS CUI [2,3]
C1277698
Planned relative time
Descripción

Please fill out this item for every timepoint to match the actual time with the planned relative time.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1301732
UMLS CUI [1,2]
C0011008
UMLS CUI [1,3]
C1277698
UMLS CUI [2,1]
C1301732
UMLS CUI [2,2]
C0040223
UMLS CUI [2,3]
C1277698
Pharmacodynamics Blood
Descripción

Pharmacodynamics Blood

Alias
UMLS CUI-1
C0243145
UMLS CUI-2
C0005767
Date and actual time sample taken
Descripción

Date and actual time sample taken

Tipo de datos

datetime

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C1277698
UMLS CUI [2,1]
C0237400
UMLS CUI [2,2]
C0040223
UMLS CUI [2,3]
C1277698
Planned relative time
Descripción

Please fill out this item for every timepoint to match the actual time with the planned relative time.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1301732
UMLS CUI [1,2]
C0011008
UMLS CUI [1,3]
C1277698
UMLS CUI [2,1]
C1301732
UMLS CUI [2,2]
C0040223
UMLS CUI [2,3]
C1277698
Volver a la parte superior de la página

Similar models

Laboratory Results

12 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative documentation
C1320722 (UMLS CUI-1)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Item Group
Liver Events Assessment
C0023901 (UMLS CUI-1)
C0441471 (UMLS CUI-2)
Liver chemistry results
Item
Have liver chemistry (ALT, AST, alkaline phosphatase, total bilirubin, or Gammaglutamyltranspeptidase) results reached or exceeded protocol-defined investigational product stopping criteria?
boolean
C0023901 (UMLS CUI [1,1])
C0439093 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C2746065 (UMLS CUI [1,4])
C0243161 (UMLS CUI [1,5])
C0001899 (UMLS CUI [2])
C0004002 (UMLS CUI [3])
C0002059 (UMLS CUI [4])
C0368753 (UMLS CUI [5])
C0017040 (UMLS CUI [6])
Item Group
Pharmacokinetics Blood
C0031328 (UMLS CUI-1)
C0005767 (UMLS CUI-2)
Date and actual time sample taken
Item
Date and actual time sample taken
datetime
C0011008 (UMLS CUI [1,1])
C1277698 (UMLS CUI [1,2])
C0237400 (UMLS CUI [2,1])
C0040223 (UMLS CUI [2,2])
C1277698 (UMLS CUI [2,3])
Item
Planned relative time
integer
C1301732 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C1277698 (UMLS CUI [1,3])
C1301732 (UMLS CUI [2,1])
C0040223 (UMLS CUI [2,2])
C1277698 (UMLS CUI [2,3])
Planned relative time
Code List
Planned relative time
CL Item
Predose (1)
CL Item
0.5hr (2)
CL Item
1hr (3)
CL Item
2hr (4)
CL Item
3hr (5)
CL Item
4hr (6)
CL Item
6hr (7)
CL Item
9hr (8)
CL Item
12hr (9)
CL Item
18hr (10)
CL Item
24hr (11)
CL Item
32hr (12)
CL Item
48hr (13)
CL Item
72hr (14)
CL Item
96hr (15)
Item Group
Pharmacodynamics Blood
C0243145 (UMLS CUI-1)
C0005767 (UMLS CUI-2)
Date and actual time sample taken
Item
Date and actual time sample taken
datetime
C0011008 (UMLS CUI [1,1])
C1277698 (UMLS CUI [1,2])
C0237400 (UMLS CUI [2,1])
C0040223 (UMLS CUI [2,2])
C1277698 (UMLS CUI [2,3])
Item
Planned relative time
integer
C1301732 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C1277698 (UMLS CUI [1,3])
C1301732 (UMLS CUI [2,1])
C0040223 (UMLS CUI [2,2])
C1277698 (UMLS CUI [2,3])
undefined item
Code List
Planned relative time
CL Item
Predose (1)
CL Item
0.5hr (2)
CL Item
1hr (3)
CL Item
2hr (4)
CL Item
3hr (5)
CL Item
4hr (6)
CL Item
6hr (7)
CL Item
9hr (8)
CL Item
12hr (9)
CL Item
18hr (10)
CL Item
24hr (11)
CL Item
32hr (12)
CL Item
48hr (13)
CL Item
72hr (14)
CL Item
96hr (15)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial